The homocysteine controversy
Open Access
- 22 June 2010
- journal article
- review article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 34 (1), 93-99
- https://doi.org/10.1007/s10545-010-9151-1
Abstract
Mild to moderate hyperhomocysteinemia has been identified as a strong predictor of cardiovascular disease, independent from classical atherothrombotic risk factors. In the last decade, a number of large intervention trials using B vitamins have been performed and have shown no benefit of homocysteine‐lowering therapy in high‐risk patients. In addition, Mendelian randomization studies failed to convincingly demonstrate that a genetic polymorphism commonly associated with higher homocysteine levels (methylenetetrahydrofolate reductase 677 C>T) is a risk factor for cardiovascular disease. Together, these findings have cast doubt on the role of homocysteine in cardiovascular disease pathogenesis, and the homocysteine hypothesis has turned into a homocysteine controversy. In this review, we attempt to find solutions to this controversy. First, we explain that the Mendelian randomization analyses have limitations that preclude final conclusions. Second, several characteristics of intervention trials limit interpretation and generalizability of their results. Finally, the possibility that homocysteine lowering is in itself beneficial but is offset by adverse side effects of B vitamins on atherosclerosis deserves serious attention. As we explain, such side effects may relate to direct adverse effects of the B‐vitamin regimen (in particular, the use of high‐dose folic acid) or to proinflammatory and proproliferative effects of B vitamins on advanced atherosclerotic lesions.This publication has 26 references indexed in Scilit:
- Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical TrialJNCI Journal of the National Cancer Institute, 2009
- A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophagesBlood, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Murine Models of Hyperhomocysteinemia and Their Vascular PhenotypesArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Mendelian Randomisation and Causal Inference in Observational EpidemiologyPLoS Medicine, 2008
- Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient miceLife Sciences, 2007
- Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?BMJ, 2005
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseThe New England Journal of Medicine, 2005
- Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemiaCell and tissue research, 2005
- Studies on the polyglutamate specificity of methylenetetrahydrofolate dehydrogenase from pig liverBiochemistry, 1984